ZMYND12

gene
On this page

Also known as DKFZp434N2435

Summary

ZMYND12 (zinc finger MYND-type containing 12, HGNC:21192) is a protein-coding gene on chromosome 1p34.2, encoding Zinc finger MYND domain-containing protein 12 (Q9H0C1). Required for sperm flagellum function and male fertility.

Predicted to enable zinc ion binding activity. Involved in sperm axoneme assembly. Located in sperm flagellum.

Source: NCBI Gene 84217 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 61 total — 1 pathogenic
  • MANE Select transcript: NM_032257

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:21192
Approved symbolZMYND12
Namezinc finger MYND-type containing 12
Location1p34.2
Locus typegene with protein product
StatusApproved
AliasesDKFZp434N2435
Ensembl geneENSG00000066185
Ensembl biotypeprotein_coding
Entrez84217

Gene structure

Transcript identifiers

Ensembl transcripts: 5 — 2 protein_coding, 2 nonsense_mediated_decay, 1 retained_intron

ENST00000372565, ENST00000461083, ENST00000475426, ENST00000611861, ENST00000862983

RefSeq mRNA: 2 — MANE Select: NM_032257 NM_001146192, NM_032257

CCDS: CCDS467

Canonical transcript exons

ENST00000372565 — 8 exons

ExonStartEnd
ENSE000008701694244846742448638
ENSE000011901094243527442435385
ENSE000014361494243314342433288
ENSE000018969154243032942430858
ENSE000035358314243642142436543
ENSE000035805184243985642440025
ENSE000036291844244991842450059
ENSE000036822224245588842456022

Expression profiles

Bgee: expression breadth ubiquitous, 183 present calls, max score 94.68.

FANTOM5 (CAGE): breadth broad, TPM avg 1.8569 / max 180.4340, expressed in 824 samples.

FANTOM5 promoters (3 alternative TSS)

Promoter IDTPM avgSamples expressed
119891.5328720
119910.286483
119900.03776

Top tissues by expression

246 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
spermCL:000001994.68gold quality
bronchial epithelial cellCL:000232894.31gold quality
bronchusUBERON:000218592.81gold quality
right uterine tubeUBERON:000130289.48gold quality
left testisUBERON:000453389.39gold quality
testisUBERON:000047388.41gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047388.15gold quality
right testisUBERON:000453488.06gold quality
adult organismUBERON:000702387.23gold quality
oviduct epitheliumUBERON:000480486.72gold quality
olfactory segment of nasal mucosaUBERON:000538685.10gold quality
caput epididymisUBERON:000435883.54gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099182.25gold quality
tibialis anteriorUBERON:000138581.63silver quality
mucosa of paranasal sinusUBERON:000503080.43gold quality
fallopian tubeUBERON:000388979.91gold quality
ileal mucosaUBERON:000033177.66gold quality
corpus epididymisUBERON:000435977.63gold quality
epithelium of nasopharynxUBERON:000195176.39gold quality
C1 segment of cervical spinal cordUBERON:000646976.16gold quality
hypothalamusUBERON:000189875.73gold quality
right adrenal glandUBERON:000123375.29gold quality
adenohypophysisUBERON:000219675.13gold quality
right adrenal gland cortexUBERON:003582774.68gold quality
adult mammalian kidneyUBERON:000008274.64gold quality
pituitary glandUBERON:000000774.13gold quality
right lobe of liverUBERON:000111473.94gold quality
caudate nucleusUBERON:000187373.53gold quality
spinal cordUBERON:000224073.47gold quality
prefrontal cortexUBERON:000045172.95gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 1.

ExperimentMarker?Max mean expression
E-ANND-3yes5.48

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

29 targeting ZMYND12, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-548P99.9872.253784
HSA-MIR-433-3P99.9869.371203
HSA-MIR-520D-5P99.9873.344883
HSA-MIR-524-5P99.9873.434882
HSA-MIR-551B-5P99.9671.283493
HSA-MIR-129799.9173.413162
HSA-MIR-427199.8868.322244
HSA-MIR-62399.7668.161170
HSA-MIR-6764-5P99.7567.892304
HSA-MIR-4755-5P99.7170.342716
HSA-MIR-5006-3P99.7170.262728
HSA-MIR-494-3P99.7071.452795
HSA-MIR-7-5P99.6770.531809
HSA-MIR-6887-3P99.6667.831778
HSA-MIR-1915-3P99.5866.791988
HSA-MIR-432899.5771.064094
HSA-MIR-330-3P99.4169.952521
HSA-MIR-569799.3967.741249
HSA-MIR-612899.3367.831581
HSA-MIR-393898.7266.07834
HSA-MIR-374B-3P98.6368.241360
HSA-MIR-204-3P97.8066.841656
HSA-MIR-365297.7165.431890
HSA-MIR-4646-5P97.7066.841692
HSA-MIR-431497.5067.301369
HSA-MIR-443097.4765.611813
HSA-MIR-426496.3564.761480
HSA-MIR-1245A96.3366.25498
HSA-MIR-807996.3366.11484

Literature-anchored findings (GeneRIF, showing 1)

  • Novel axonemal protein ZMYND12 interacts with TTC29 and DNAH1, and is required for male fertility and flagellum function. (PMID:37934199)

Cross-species orthologs

3 orthologs

OrganismSymbolGene ID
danio_reriozmynd12ENSDARG00000017055
mus_musculusZmynd12ENSMUSG00000070806
rattus_norvegicusZmynd12ENSRNOG00000022199

Paralogs (2): PDCD2 (ENSG00000071994), PDCD2L (ENSG00000126249)

Protein

Protein identifiers

Zinc finger MYND domain-containing protein 12Q9H0C1 (reviewed: Q9H0C1)

All UniProt accessions (3): Q9H0C1, A0A087WUN3, A0A087WZE7

UniProt curated annotations — full annotation on UniProt →

Function. Required for sperm flagellum function and male fertility.

Subcellular location. Cell projection. Cilium. Flagellum.

Tissue specificity. Expressed predominantly in the testis.

Disease relevance. Loss-of-function variants in ZMYND12 may play a role in male infertility characterized by severe asthenozoospermia with over 5% of the spermatozoa displaying flagellar abnormalities such as short, absent, coiled, bent, or irregular flagella.

RefSeq proteins (2): NP_001139664, NP_115633* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR002893Znf_MYNDDomain
IPR011990TPR-like_helical_dom_sfHomologous_superfamily
IPR053248Zinc_finger_MYND_domainFamily

Pfam: PF01753

UniProt features (16 total): binding site 8, repeat 2, sequence variant 2, sequence conflict 2, chain 1, zinc finger region 1

Structure

Experimental structures (PDB)

1 structures.

PDBMethodResolution (Å)
8J07ELECTRON MICROSCOPY4.1

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q9H0C1-F190.590.74

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Ligand- & substrate-binding residues (8): 50; 54; 17; 20; 28; 31; 37; 41

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 90 (showing top): FXR_IR1_Q6, IVANOVA_HEMATOPOIESIS_LATE_PROGENITOR, GOBP_MALE_GAMETE_GENERATION, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_CILIUM_ORGANIZATION, GOBP_CILIUM_MOVEMENT, USF_01, chr1p34, GOBP_CILIUM_OR_FLAGELLUM_DEPENDENT_CELL_MOTILITY, GOBP_ORGANELLE_ASSEMBLY, GOBP_CELLULAR_PROCESS_INVOLVED_IN_REPRODUCTION_IN_MULTICELLULAR_ORGANISM, GOBP_MICROTUBULE_BUNDLE_FORMATION, GATA1_03, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, USF_02

GO Biological Process (2): sperm axoneme assembly (GO:0007288), flagellated sperm motility (GO:0030317)

GO Molecular Function (3): zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (4): sperm flagellum (GO:0036126), cilium (GO:0005929), motile cilium (GO:0031514), cell projection (GO:0042995)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
developmental process involved in reproduction1
axoneme assembly1
sperm flagellum assembly1
cilium-dependent cell motility1
cilium movement involved in cell motility1
sperm motility1
transition metal ion binding1
binding1
cation binding1
9+2 motile cilium1
intraciliary transport particle1
membrane-bounded organelle1
plasma membrane bounded cell projection1
cilium1
cellular anatomical structure1

Protein interactions and networks

STRING

222 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZMYND12ARMH2H3BNL8654
ZMYND12DYDC1Q8WWB3512
ZMYND12CACYBPQ9HB71497
ZMYND12CCDC150Q8NCX0480
ZMYND12ZNF497Q6ZNH5479
ZMYND12ZNF34Q8IZ26449
ZMYND12LYG1Q8N1E2449
ZMYND12CCDC30Q5VVM6447
ZMYND12TTC29Q8NA56420
ZMYND12FAM120AQ9NZB2419
ZMYND12CFAP57Q96MR6417
ZMYND12CIAO1O76071415
ZMYND12SPEF2Q9C093414
ZMYND12SCMH1Q96GD3403
ZMYND12FBXL5Q9UKA1398

IntAct

267 interactions, top by confidence:

ABTypeScore
ZMYND12THOC1psi-mi:“MI:0915”(physical association)0.560
ARMC8ZMYND12psi-mi:“MI:0915”(physical association)0.560
THOC1ZMYND12psi-mi:“MI:0915”(physical association)0.560
MAD2L2ZMYND12psi-mi:“MI:0915”(physical association)0.560
PRR35ZMYND12psi-mi:“MI:0915”(physical association)0.560
QARS1ZMYND12psi-mi:“MI:0915”(physical association)0.560
TEPSINZMYND12psi-mi:“MI:0915”(physical association)0.560
ZMYND12ZNF148psi-mi:“MI:0915”(physical association)0.560
BMAL1ZMYND12psi-mi:“MI:0915”(physical association)0.560
NUDT22ZMYND12psi-mi:“MI:0915”(physical association)0.560
THRSPZMYND12psi-mi:“MI:0915”(physical association)0.560
ZMYND12SPG21psi-mi:“MI:0915”(physical association)0.560
MSRB3ZMYND12psi-mi:“MI:0915”(physical association)0.560
TTC29ZMYND12psi-mi:“MI:0915”(physical association)0.560
KANK2ZMYND12psi-mi:“MI:0915”(physical association)0.560
POM121ZMYND12psi-mi:“MI:0915”(physical association)0.560
PPP1R18ZMYND12psi-mi:“MI:0915”(physical association)0.560
ZMYND12CHCHD2psi-mi:“MI:0915”(physical association)0.560
HOXB5ZMYND12psi-mi:“MI:0915”(physical association)0.560
ZMYND12ABI2psi-mi:“MI:0915”(physical association)0.560
ZMYND12AIRIMpsi-mi:“MI:0915”(physical association)0.560
STRA8ZMYND12psi-mi:“MI:0915”(physical association)0.560
TFAP2DZMYND12psi-mi:“MI:0915”(physical association)0.560
SOHLH1ZMYND12psi-mi:“MI:0915”(physical association)0.560
CWF19L2ZMYND12psi-mi:“MI:0915”(physical association)0.560
LMO4ZMYND12psi-mi:“MI:0915”(physical association)0.560
LMO2ZMYND12psi-mi:“MI:0915”(physical association)0.560
ZMYND12PICK1psi-mi:“MI:0915”(physical association)0.560
HDAC4ZMYND12psi-mi:“MI:0915”(physical association)0.560
PRKAA2ZMYND12psi-mi:“MI:0915”(physical association)0.560

BioGRID (81): ZMYND12 (Two-hybrid), ZMYND12 (Two-hybrid), ZMYND12 (Two-hybrid), ZMYND12 (Two-hybrid), ZMYND12 (Two-hybrid), HDAC4 (Two-hybrid), GPKOW (Two-hybrid), THOC1 (Two-hybrid), SPG21 (Two-hybrid), PICK1 (Two-hybrid), TXN2 (Two-hybrid), GSTZ1 (Two-hybrid), HSF4 (Two-hybrid), SH2D4A (Two-hybrid), AES (Two-hybrid)

ESM2 similar proteins: A3KMX7, A5PKL6, F1MKX4, F1R2X6, F4IVI0, O94952, P35574, P42700, P51398, P97259, Q08834, Q09328, Q14997, Q2TBQ7, Q2TBU5, Q3U1V6, Q3V3E1, Q498D5, Q4R6Y8, Q5F204, Q5I0G3, Q5IH13, Q5IH14, Q5R5S1, Q5R7E8, Q5RL51, Q5SSW2, Q6IQC7, Q6NRP2, Q6NTT6, Q6P2P2, Q6YXW6, Q8BGG7, Q8C5P5, Q8CEL2, Q8N1I0, Q8NEC7, Q8NHU2, Q8R4G6, Q8TB36

Diamond homologs: Q38DX5, Q9H0C1

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

61 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic1
Likely pathogenic0
Uncertain significance44
Likely benign5
Benign1

Top pathogenic / likely-pathogenic (1)

Variant IDHGVSClassification
57093GRCh38/hg38 1p34.2-34.1(chr1:40693289-44514104)x1Pathogenic

SpliceAI

1158 predictions. Top by Δscore:

VariantEffectΔscore
1:42433286:CAT:Cacceptor_gain1.0000
1:42433288:TCT:Tacceptor_loss1.0000
1:42433289:C:CCacceptor_gain1.0000
1:42433290:T:Aacceptor_loss1.0000
1:42433294:T:Cacceptor_gain1.0000
1:42433294:T:TCacceptor_gain1.0000
1:42436539:TAAAT:Tacceptor_gain1.0000
1:42436543:TCTA:Tacceptor_loss1.0000
1:42436544:CTATA:Cacceptor_loss1.0000
1:42439841:A:Cdonor_gain1.0000
1:42439845:A:ACdonor_gain1.0000
1:42439899:G:Cdonor_gain1.0000
1:42440024:ACCT:Aacceptor_loss1.0000
1:42440025:CCT:Cacceptor_loss1.0000
1:42440026:C:Aacceptor_loss1.0000
1:42440027:T:Aacceptor_loss1.0000
1:42448462:CTCA:Cdonor_loss1.0000
1:42448463:TCACC:Tdonor_loss1.0000
1:42448464:CACCA:Cdonor_loss1.0000
1:42448465:A:ACdonor_gain1.0000
1:42448465:ACCAA:Adonor_loss1.0000
1:42448466:C:CCdonor_gain1.0000
1:42448466:C:Gdonor_loss1.0000
1:42448634:TACTT:Tacceptor_gain1.0000
1:42448636:CTT:Cacceptor_gain1.0000
1:42448639:C:CCacceptor_gain1.0000
1:42450055:CCCCA:Cacceptor_gain1.0000
1:42450056:CCCA:Cacceptor_gain1.0000
1:42450056:CCCAC:Cacceptor_gain1.0000
1:42450057:CCAC:Cacceptor_gain1.0000

AlphaMissense

2379 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
1:42439923:C:GR176P0.996
1:42439866:A:GL195P0.989
1:42439879:C:GA191P0.987
1:42439984:C:GA156P0.987
1:42449952:C:GR73P0.986
1:42436477:C:GA221P0.985
1:42439914:C:TG179E0.985
1:42448607:G:TA95D0.985
1:42455916:A:GC28R0.985
1:42436479:A:GL220P0.984
1:42439915:C:GG179R0.984
1:42439915:C:TG179R0.984
1:42448559:G:TA111D0.984
1:42436476:G:TA221D0.983
1:42448482:C:GA137P0.983
1:42448572:C:GA107P0.983
1:42455949:A:GC17R0.981
1:42439992:A:GL153P0.980
1:42448571:G:TA107D0.980
1:42455948:C:TC17Y0.980
1:42448476:C:GA139P0.978
1:42448490:A:GL134P0.978
1:42455927:G:TA24D0.978
1:42448560:C:GA111P0.977
1:42439878:G:TA191D0.976
1:42448481:G:TA137D0.976
1:42455915:C:GC28S0.976
1:42455916:A:TC28S0.976
1:42448547:A:GL115P0.975
1:42455907:A:GC31R0.975

dbSNP variants (sampled 300 via entrez): RS1000004996 (1:42438845 G>A,T), RS1000071534 (1:42437414 AT>A), RS1000258260 (1:42447838 C>G), RS1000346565 (1:42432229 T>A,G), RS1000546667 (1:42456445 T>C,G), RS1000751706 (1:42452892 G>A), RS1000860421 (1:42446233 A>G), RS1000922271 (1:42450874 T>C), RS1000987071 (1:42450666 G>A,T), RS1001146650 (1:42440503 A>G), RS1001256461 (1:42444032 AT>A,ATT), RS1001334913 (1:42446468 A>G), RS1001403332 (1:42446973 T>A,G), RS1001616426 (1:42435487 C>G), RS1001669048 (1:42435173 T>A,G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

24 total (human), top 24 by PubMed support.

ChemicalActions (top 5)PubMed papers
Benzo(a)pyrenedecreases expression, increases methylation2
Nickeldecreases expression2
methyleugenoldecreases expression1
propionaldehydeincreases expression1
pirinixic acidaffects binding, decreases expression, increases activity1
bisphenol Aaffects cotreatment, increases expression1
sulforaphanedecreases expression1
tris(1,3-dichloro-2-propyl)phosphateincreases expression1
CGP 52608affects binding, increases reaction1
entinostatincreases expression1
jinfukangincreases expression1
Air Pollutantsincreases abundance, increases expression1
Dexamethasoneincreases expression, affects cotreatment1
Indomethacinaffects cotreatment, increases expression1
N-Nitrosopyrrolidinedecreases expression1
Phthalic Acidsdecreases methylation1
Silicon Dioxidedecreases expression1
Smokeincreases abundance, increases expression1
Tetrachlorodibenzodioxinaffects expression1
Tobacco Smoke Pollutiondecreases expression1
1-Methyl-3-isobutylxanthineaffects cotreatment, increases expression1
Aflatoxin B1decreases expression1
Cadmium Chloridedecreases expression1
Okadaic Aciddecreases expression1

Cellosaurus cell lines

3 cell lines: 3 embryonic stem cell

First 10 cell lines (id-ordered, not curated):

CellosaurusNameCategorySex
CVCL_A8E7SEES3-1V human ZMYND12, clone1Embryonic stem cellMale
CVCL_A8E8SEES3-1V human ZMYND12, clone2Embryonic stem cellMale
CVCL_A8E9SEES3-1V human ZMYND12, clone3Embryonic stem cellMale

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.